Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19). A combination of two monoclonal antibodies significantly reduced airway viral load and virus-induced pathology in models of both mild and severe… Continue reading Casirivimab and Imdevimab (Regen-cov) (Covid-19)
ONAFHANKLIK 